Treatment of hypertension with spironolactone. Double-blind study
- 12 December 1966
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 198 (11) , 1143-1149
- https://doi.org/10.1001/jama.198.11.1143
Abstract
A double-blind study of patients with essential hypertension was performed in order to determine which dosage of spironolactone (25 mg, 100 mg, or 200 mg daily), with or without hydrochlorothiazide, had the optimum hypotensive effect. The data were analyzed by 2 different statistical methods, in each of which multivariate analysis of variance was used. Both methods led to the conclusion that the most efficacious treatment regimen tested was spironolactone at a daily dosage of 100 mg, without hydrochlorothiazide.This publication has 4 references indexed in Scilit:
- Effects of work stress on psychological well-being and job satisfaction: The stress-buffering role of social supportAustralian Journal of Psychology, 1993
- A Double-Blind Evaluation of Antihypertensive DrugsAngiology, 1964
- The Vascular Effect of the Thiazide DiureticsArchives of internal medicine (1960), 1963
- Spironolactone in Hypertensive PatientsArchives of internal medicine (1960), 1961